Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial

NCT02256462 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Adalimumab

Sponsor

Schneider Children's Medical Center, Israel